OTHER · Unmapped registry intervention
Tissue
Find medicine records ·
Find other trials using this name
Clinical trial
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
NCT01596920
Study summary
ClinicalTrials.govGrafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
Control
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Advertisement
Conditions
Diabetic Foot Ulcersunresolved
Interventions
Sponsors & collaborators
Osiris Therapeuticslead sponsor
Mapped research locations
DallasTexas, United States1San AntonioTexas, United States1ClevelandOhio, United States1ColumbusOhio, United States1DurhamNorth Carolina, United States1JacksonvilleFlorida, United States1Chapel HillNorth Carolina, United States1Toms RiverNew Jersey, United States1GlendaleArizona, United States1EncinitasCalifornia, United States1AltoonaPennsylvania, United States1MontgomeryAlabama, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01596920 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.